Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - Weslaco

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

1330 E 6th Street, Suite 204
Weslaco, TX 78596
P: (956) 969-0021

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - San Antonio

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

2130 NE Loop 410, Suite 100
San Antonio, TX 78217
P: (210) 656-7177

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - San Antonio

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

18707 Hardy Oaks Blvd.
Suite 320
San Antonio, TX 78258
P: (210) 545-6972

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - San Antonio

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

5206 Research Dr
San Antonio, TX 75204
P: (210) 595-5300

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

8820 Huron St
Thornton, CO 80260
P: (303) 386-7622

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Compass Oncology - Tigard

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

12123 SW 69th Avenue
Tigard, OR 97223
P: (971) 708-7600

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Compass Oncology - Vancouver

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

210 SE 136th Ave
Vancouver, WA 98684
P: (360) 944-9889

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Texas Oncology - Waco

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

6520 Horizon Circle
Waco, TX 76712
P: (254) 755-4460

More Details View Practice Page
1 2 3 4

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.